# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA2023560 | CF3-lmph | Activity | 0 | ALA2027537 | Not Active | Homo sapiens | |||||
2. | ALA2023560 | CF3-lmph | IC50 | > | 1000 | uM | ALA2027524 | nM | ||||
3. | ALA2023560 | CF3-lmph | IC50 | > | 1000 | uM | ALA2027523 | nM | ||||
4. | ALA2023560 | CF3-lmph | IC50 | > | 1000 | uM | ALA2027521 | nM | ||||
5. | ALA2023560 | CF3-lmph | IC50 | > | 1000 | uM | ALA2027520 | nM | ||||
6. | ALA2023560 | CF3-lmph | IC50 | > | 1000 | uM | ALA2027519 | nM | ||||
7. | ALA2023560 | CF3-lmph | Imax | < | 1 | % | ALA2027532 | % | ||||
8. | ALA2023560 | CF3-lmph | Imax | < | 1 | % | ALA2027531 | % | ||||
9. | ALA2023560 | CF3-lmph | Ki | = | 24 | uM | ALA2027518 | 4.62 | nM | Sus scrofa | ||
10. | ALA2023560 | CF3-lmph | INH | > | 25 | % | ALA2027547 | % | Sus scrofa | |||
11. | ALA2023560 | CF3-lmph | Imax | = | 30 | % | ALA2027530 | % | ||||
12. | ALA2023560 | CF3-lmph | Imax | = | 50 | % | ALA2027541 | % | Homo sapiens | |||
13. | ALA2023560 | CF3-lmph | Imax | = | 72 | % | ALA2027525 | % | Sus scrofa | |||
14. | ALA2023560 | CF3-lmph | Imax | = | 72 | % | ALA2027526 | % | Sus scrofa | |||
15. | ALA2023560 | CF3-lmph | Imax | = | 80 | % | ALA2027540 | % | Homo sapiens | |||
16. | ALA2023560 | CF3-lmph | IC50 | = | 98 | uM | ALA2027518 | 4.01 | nM | Sus scrofa | ||
17. | ALA2023560 | CF3-lmph | IC50 | = | 210 | uM | ALA2027522 | nM | ||||
18. | ALA2023560 | CF3-lmph | INH | 0 | ALA2027533 | Active | % | Sus scrofa | ||||
19. | ALA2023560 | CF3-lmph | INH | 0 | ALA2027538 | Dose-dependent effect | % | Homo sapiens | ||||
20. | ALA2023560 | CF3-lmph | INH | 0 | ALA2027539 | Dose-dependent effect | % | Homo sapiens |